VANCOUVER, British Columbia, October 04, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, announces the Company is extending 1,376,050 of its share purchase warrants (the “Warrants”). The Warrants were issued on October 25, 2021 in connection with the conversion of 2,752,100 special warrants previously issued by the Company.
The expiry date of the Warrants will be extended from October 25, 2023 to October 25, 2026. All other terms of the Warrants will remain unchanged.
Holders of the Warrants are advised that replacement warrant certificates will not be issued and that this announcement serves as notice of the amendments. Original warrant certificates must be presented to the Company in order to exercise the Warrants. The Company will file a Form 13 with the Canadian Securities Exchange in connection with the amendment.
On Behalf of the Board of Directors,
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Matt Chatterton, Director
Tel: +1 778.613.2082
Media Inquiries email@example.com
Certain information contained herein constitutes “forward-looking information” under Canadian securities legislation. Forward-looking information includes, but is not limited to, the completion of Warrant extension. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “will” or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed this press release and does not accept responsibility for the adequacy or accuracy of this news release.